Dale G. Renlund - Concepedia

Author

Dale G. Renlund

Also Known As

D G Renlund, D Renlund, D. G. RENLUND, D. G. Renlund, D. Renlund, D.G Renlund, D.G. Renlund, DALE G. RENLUND, Dale G Renlund, Dale G. Renlund

273

Publications

12.4K

Citations

H-Index

139

Concepts

All Affiliations

University of Utah LDS Hospital Intermountain Medical Center University of Utah Hospital Intermountain Healthcare

About

Dale G. Renlund is an author at University of Utah specializing in medicine, cardiology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	2	2	152
2	Health Sciences	2	2	94
3	Arts	1	1	53
4	Business	1	1	163
5	Education	1	1	10

Dale G. Renlund

125

Publications

11.4K

Citations

H-Index

Page 1

	Year	Citations
Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk? Benjamin D. Horne, Jeffrey L. Anderson, Jerry M. John, Journal of the American College of Cardiology Genetic DeterminantCardiovascular EpidemiologyCardiovascular DiseaseCardiovascular RiskGenetic Epidemiology	2005	963
Ischemic Heart Disease Events Triggered by Short-Term Exposure to Fine Particulate Air Pollution C. Arden Pope, Joseph B Muhlestein, Heidi T. May, Circulation	2006	617
A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1 Jon Kobashigawa, L.W. Miller, Dale G. Renlund, Transplantation	1998	613
Risk Factors Predictive of Right Ventricular Failure After Left Ventricular Assist Device Implantation Stavros G. Drakos, Lindsay Janicki, Benjamin D. Horne, The American Journal of Cardiology Heart FailureDevice TherapyCardiovascular DiseasePatient SafetyRisk Factors Predictive	2010	437
A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation Thomas C. Merigan, Dale G. Renlund, Susan Keay, New England Journal of Medicine	1992	381
Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study Stephanie L. Olsen, Edward M. Gilbert, Dale G. Renlund, Journal of the American College of Cardiology CardiomyopathyHeart FailureChronic Heart FailureStructural Heart DiseaseCardiovascular Disease	1995	372
Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. Elizabeth H. Hammond, Robert L. Yowell, Shinichi Nunoda, PubMed Clinical ImplicationsImmunologyTransplantation MedicinePathologyVascular Rejection	1990	321
A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus11This study was sponsored by a grant from Fujisawa USA, Deerfield, Illinois.22The authors were working on behalf of the Tacrolimus US Heart Transplant Multicenter Study Group. Other members of the Study Group included (principal investigator listed first): UTAH Cardiac Transplant Program, Salt Lake City, Utah: David O. Taylor, MD, Dale G. Renlund, MD, Abdallah G. Kfoury, MD; St. Luke’s Episcopal Hospital/Texas Heart Institute, Houston, Texas: O. H. Frazier, MD, Branislav Radovancevic, MD, Edward K. Massin, MD; University of Wisconsin Hospitals and Clinics, Madison, Wisconsin: Robert M. Mentzer, Jr., MD, Charles C. Canver, MD, Robert B. Love, MD; Ochsner Medical Foundation, New Orleans, Louisiana: Frank W. Smart, MD, Hector O. Ventura, MD, Dwight D. Stapleton, MD, Mandeep Mehra, MD; University of Southern California, Los Angeles, California: Mark L. Barr, MD, Vaugh A. Starnes, MD; Medical College of Virginia, Richmond, Virginia: David E. Tolman, MD, Albert Guerraty, MD, David Salter, MD; Cleveland Clinic Foundation, Cleveland, Ohio: James B. Young, MD; Data Management and Statistical Coordinating Center-The EMMES Corporation, Potomac, Maryland: Paul VanVeldhuisen, MS, Anne Lindblad, PhD, Anita Yaffe, MSN, MPH. David O. Taylor, Mark L. Barr, Branislav Radovančević, The Journal of Heart and Lung Transplantation	1999	316
Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant Atherosclerosis Hannah A. Valantine, Shao‐Zhou Gao, Santosh Menon, Circulation	1999	290
Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant Recipients Howard J. Eisen, Jon Kobashigawa, Anne Keogh, The Journal of Heart and Lung Transplantation TransplantationCardiovascular DiseaseControlled TrialCardiopulmonary TransplantationMedicine	2005	259

Page 1